What does PPE stand for?

Palmar-Plantar Erythrodysesthesia

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Presentation Protocol Data Unit Platform Port Door Undogged Pacific Pan-Decadal Variability (climate variation) Person Per Diary Value (program ratings) Personal and Professional Development Parallel-Plate Dielectric Waveguide Employee Pension Programme Pacific Performance Engineering (Fullerton, CA) Packet Processing Engine Pallet Position Equivalent (military transportation)		Paper. Print. Environment. Parallel Page Engine (Oracle portal) Parapneumonic Effusion Parti Populaire Européen (French: European People's Party) Partnership for Public Engagement (UK) Password Policy Enforcer (network security software) PAVE PAWS East Pay Period Ending Per Person Expenditure (consumer spending) Permissible Exposure Limit (safety regulation)

Samples in periodicals archive:

The most frequently occurring Grade 3 and Grade 4 adverse events (>5%) regardless of relationship to drug were: fatigue, headache, palmar-plantar erythrodysesthesia, confusional state, alanine aminotransferase increase, convulsion, lymphopenia, hypophosphatemia, lipase increase, diarrhea, aspartate aminotransferase increase, and gait disturbance.

Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 ...

Adverse events of special interest were: hypertension (all incidences, 39%; Grade 3/4, 7%), palmar-plantar erythrodysesthesia (30%; 7%), bleeding events (28%; 9%), proteinuria (26%; 0%), pulmonary embolism (9%; 7%) and craniotomy wound dehiscence (4%; 2%).

Exelixis and BMS Report Phase 2 Data to Be Presented at ASCO for ...

VioQuest Pharmaceuticals is continuing its parallel development of Xyfid for the prevention of palmar-plantar erythrodysesthesia (PPE), also known as hand-foot syndrome (HFS).

VioQuest Pharmaceuticals Receives 510(k) Response from FDA for ...